Benjamin Eckhardt
Impact in
- Hepatology top 2%
- Hepatitis C virus research
- Liver Disease and Transplantation
- Epidemiology top 10%
- HIV, Drug Use, Sexual Risk
- Hepatitis B Virus Studies
- Liver Disease Diagnosis and Treatment
Papers in
- Epidemiology 16
- HIV, Drug Use, Sexual Risk 12
- Hepatitis B Virus Studies 7
- Hepatology 16
- Hepatitis C virus research 16
- Co-authors
- Brian R. Edlin (4 shared papers)Marla A. Shu (2 shared papers)Tracy Swan (1 shared paper)Scott D. Holmberg (1 shared paper)Kristen Marks (12 shared papers)Pedro Mateu‐Gelabert (17 shared papers)Shashi N. Kapadia (16 shared papers)Chunki Fong (12 shared papers)
- Journals
- Open Forum Infectious Diseases (5 papers)PLoS ONE (3 papers)Harm Reduction Journal (3 papers)Journal of Hepatology (1 paper)Hepatology (1 paper)
- Partner nations
- United StatesCanada
In The Last Decade
Benjamin Eckhardt
32 papers receiving 786 citations
Benjamin Eckhardt's Hit Papers
Peers
Comparison fields: 5 of 66
- Hepatology 454
- Epidemiology 308
- Emergency Medicine 45
- Infectious Diseases 89
- Virology 13
Countries citing papers authored by Benjamin Eckhardt
This map shows the geographic impact of Benjamin Eckhardt's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Benjamin Eckhardt with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Benjamin Eckhardt more than expected).
Fields of papers citing papers by Benjamin Eckhardt
This network shows the impact of papers produced by Benjamin Eckhardt. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Benjamin Eckhardt. The network helps show where Benjamin Eckhardt may publish in the future.
Co-authors
The 25 scholars most cited alongside Benjamin Eckhardt, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 32 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Toward a more accurate estimate of the prevalence of hepatitis C in the United States Hit paper breakdown → | 2015 | 329 |
| 2 | 2017 | 49 | |
| 3 | 2022 | 49 | |
| 4 | 2021 | 46 | |
| 5 | 2018 | 43 | |
| 6 | 2012 | 40 | |
| 7 | 2019 | 40 | |
| 8 | 2020 | 30 | |
| 9 | 2021 | 25 | |
| 10 | 2022 | 18 | |
| 11 | 2022 | 17 | |
| 12 | 2012 | 15 | |
| 13 | 2019 | 15 | |
| 14 | 2022 | 14 | |
| 15 | 2023 | 12 | |
| 16 | 2020 | 12 | |
| 17 | Rapid Treatment Initiation for Hepatitis C Virus Infection: Potential Benefits, Current Limitations, and Real-World Examples. | 2022 | 11 |
| 18 | 2017 | 7 | |
| 19 | 2023 | 5 | |
| 20 | 2019 | 4 |
About Benjamin Eckhardt
Benjamin Eckhardt is a scholar working on Epidemiology, Hepatology, Infectious Diseases, Emergency Medicine and Pathology and Forensic Medicine, having authored 32 papers that have together received 803 indexed citations. Recurring topics across this work include Hepatitis C virus research (16 papers), HIV, Drug Use, Sexual Risk (12 papers), Hepatitis B Virus Studies (7 papers), HIV/AIDS Research and Interventions (4 papers), HIV-related health complications and treatments (4 papers), HIV/AIDS drug development and treatment (2 papers), Vitamin D Research Studies (1 paper) and Leptospirosis research and findings (1 paper). The work is most often cited by research in Hepatology (454 citations), Epidemiology (308 citations), Emergency Medicine (45 citations), Infectious Diseases (89 citations) and Virology (13 citations). Benjamin Eckhardt has collaborated with scholars based in United States and Canada. Frequent co-authors include Brian R. Edlin, Marla A. Shu, Tracy Swan, Scott D. Holmberg, Kristen Marks, Pedro Mateu‐Gelabert, Shashi N. Kapadia, Chunki Fong, Yesenia Aponte-Meléndez and Jonathan Baghdadi. Their work appears in journals such as Open Forum Infectious Diseases, PLoS ONE, Harm Reduction Journal, Journal of Hepatology and Hepatology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.